A sterile, non-woven pad composed of hydro-desloughing, polyabsorbent fibres coated with TLC‑Ag.

FEATURES:

• Fast and effective anti-biofilm action
• Proven antimicrobial efficacy
• Complete and continuous cleaning action achieved up to 7 days 

• Comfort and ease of use

BENEFITS:

• 99.99% biofilm reduction in just 24h
• Blocks biofilm reattachment for up to 7 days
• Super anti-biofilm efficacy compared to Aquacel Ag+ Extra and Cutimed Sorbact
• Fast action: from 30 minutes on main strains
• Works against strains resistant to antibiotics (e.g MRSA, VRE)
• High affinity to vertically wick, trap and retain wound debris such as sloughy residues, microbes and biofilm
• One piece removal thanks to strong acrylic core
• Ensures pain-free care and atraumatic removal
• Conformable and easy to reposition
• Non-adherent

INDICATIONS:

All wounds at risk or with signs of local infection, from the debridement stage, including:

• Exuding wounds
• Chronic wounds
  • Leg ulcers
  • Pressure injuries
  • Diabetic foot ulcers
• Long standing acute wounds

CONTRAINDICATIONS:

• Known sensitation to silver
• UrgoClean Ag is not suitable for use as a surgical sponge for heavily bleeding wounds
• Do not use UrgoClean Ag in combination with hydrogen peroxide, organomercuric antiseptics or hexamidine
• Do not use on patients undergoing Magnetic Resonance (MRI) examination

PRECAUTIONS:

• Treatment with UrgoClean Ag should be carried out under medical supervision.
• Use of this dressing does not negate the need for appropriate systemic anti-bacterial treatment of infected wounds in line with local policy.
• The soft-adherent Silver Healing Matrix (TLC-Ag) of UrgoClean Ag adheres to latex surgical gloves. It is therefore recommended that the dressing be handled carefully, avoiding any contact with the soft-adherent side or using sterile pliers.
• Concomitant use with other local treatments is not recommended.
• Avoid contact with electrodes or conductive gels during electronic measurements, e.g. EEG and ECG.
• Clinicians / Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates.
• In the absence of any specific clinical data, use in pregnant or breast-feeding women, is not recommended.
• Do not use in a hyperbaric chamber.
• Single-use, individual packaging. Re-using a single use dressing may lead to risks of infection. Check that the sterile protector is intact before use.
• Do not re-sterilise.
• For elimination, discard according to current protocol. Discard any unused parts of the dressing.

DIRECTIONS FOR USE:

WOUND PREPARATION:

• Cleanse the wound using saline solution. In the event of prior use of an antiseptic (with the exception of contra-indicated antiseptics) carefully rinse the wound with saline solution before applying the dressing.
• The use of UrgoClean Ag does not dispense with the need for mechanical debridement when required.
• During the desloughing process, the wound may appear to be larger in size. This is due to the effective removal of slough.

DRESSING CHANGES:

• UrgoClean Ag dressings should be changed every 1 to 2 days during the wound desloughing phase, then as often as required (up to 7 days) depending on the exudate volume and the clinical condition of the wound.
• The maximal duration of the treatment with UrgoClean Ag is one month.

CLINICAL EVIDENCE:

CUTTING GUIDE: